Lou [24] demonstrated that the NF-kB inhibitor zeta (NFKBIZ) was a downstream target of NUDT21, and that MES recognition genes CHI3L1 and FN1 were differentially regulated in glioblastoma cells. The gene discussed is NUDT21; the disease is glioblastoma.